Entera Bio (ENTX) Expected to Announce Earnings on Friday

Entera Bio (NASDAQ:ENTX) is projected to release its earnings data before the market opens on Friday, March 14th. Analysts expect Entera Bio to post earnings of ($0.08) per share and revenue of $0.04 million for the quarter.

Entera Bio Stock Performance

Entera Bio stock opened at $2.06 on Wednesday. The stock has a market capitalization of $73.72 million, a price-to-earnings ratio of -7.92 and a beta of 1.62. Entera Bio has a 52-week low of $1.30 and a 52-week high of $3.35. The stock’s 50 day moving average price is $2.27 and its two-hundred day moving average price is $2.01.

Entera Bio Company Profile

Entera Bio Ltd., a clinical-stage company, focuses on the development and commercialization of orally delivered peptide and protein therapeutics for unmet medical needs. The company's product candidates include the EB612, which is in Phase II clinical trials for the treatment of hypoparathyroidism; and EB613 that has completed Phase II clinical trials for the treatment of osteoporosis, as well as is in Phase I clinical trials for the treatment of stress fractures.